| Company Announcements: (reported by the Company) |
No items found
|
| Elevator Pitch: | The CNSDose Report - powered by DNA - guides which antidepressant and dose is most appropriate. With world-first understanding of how antidepressants reach the brain, and backed by clinical trial evidence, CNSDose is the first 2nd generation pharmacogenetic report. |
| Category: | Health & biotech |
| URL: | https://www.cnsdose.com/ |
| Operational Status: | Active |
| ASX Listing Code (if applicable): | |
| Year of Commencement: | 2020 |
| Address: | Melbourne, VIC |
| State: | Victoria |
| Overseas Operations: | |
| Twitter: | Tweets by @cnsdose |
| Facebook: | https://www.facebook.com/CNSDose-1116530778364407/ |
| Linkedin: | https://www.linkedin.com/company/cnsdose |
| Founders: | |
| Awards won: | |
